What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Pioneering biostatistician and infectious disease expert Dr. Elizabeth Halloran recently transitioned to emerita after a ...

Ten years after his successful treatment at the Fred Hutch proton facility, patient Keith Abbott wrote a thank you note to ...

In this episode of Meet the Greek, Dr. Heather Parsons discusses her journey in oncology, focusing on breast cancer. She highlights the importance of circulating tumor DNA in detecting cancer and ...

Seattle — Dec. 18, 2025 — Fred Hutch Cancer Center researchers have developed a new tool that enables anyone to immediately assess their colorectal cancer risk online. Called MyGeneRisk, the free, web ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Some patients become advocates because everything went right: the diagnosis was made early, the surgery went well, the cancer-driving mutation was found and communicated to other family members, ...

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments SEATTLE — July 23, 2025 — A landmark study has ...

We’ve all heard the advice: “Eat small, frequent meals to keep your metabolism going and manage hunger.” But is this popular belief actually backed by science? A new study by Drs. Zhang and Neuhouser ...

Fred Hutch Cancer Center biostatistician Peter Gilbert, PhD, received the 2025 Marvin Zelen Leadership Award in Statistical Science from Harvard University. The award recognizes Gilbert’s ...

Some things just go together like “rock and roll” and “fish and chips” or, in molecular biology, “transcription factors” and the “nearby genes they regulate.” The standard, simplified story goes like ...

Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as ...